Literature DB >> 8381155

Characterization of the T cell receptor repertoire causing collagen arthritis in mice.

G E Osman1, M Toda, O Kanagawa, L E Hood.   

Abstract

Collagen type II-induced arthritis (CIA) is generated in susceptible rodent strains by intradermal injections of homologous or heterologous native type II collagen in complete Freund's adjuvant. Symptoms of CIA are analogous to those of the human autoimmune disease, rheumatoid arthritis. CIA is a model system for T cell-mediated autoimmune disease. To study the T cell receptor (TCR) repertoire of bovine type II-specific T cells that may be involved in the pathogenesis of CIA in DBA/1Lac.J (H-2q) mice, 13 clonally distinct T cell hybridomas specific for bovine type II collagen have been established and the alpha and beta chains of their TCRs have been analyzed. These T cell hybridomas recognize epitopes that are shared by type II collagens from distinct species and not by type I collagens, and exhibit a highly restricted TCR-alpha/beta repertoire. The alpha chains of the TCRs employ three V alpha gene subfamilies (V alpha 11, V alpha 8, and V alpha 22) and four J alpha gene segments (J alpha 42, J alpha 24, J alpha 37, and J alpha 32). The V alpha 22 is a newly identified subfamily consisting of approximately four to six members, and exhibits a high degree of polymorphism among four mouse strains of distinct V alpha haplotypes. In addition, the beta chains of the TCRs employ three V beta gene subfamilies (V beta 8, V beta 1, and V beta 6), however the V beta 8.2 gene segment is preferentially utilized (58.3%). In contrast, the J beta gene segment usage is more heterogeneous. On the basis of the highly limited TCR-alpha/beta repertoire of the TCRs of the panel of bovine type II-specific T cell hybrid clones, a significant reduction (60%) of the incidence of arthritis in DBA/1Lac.J mice is accomplished by the use of anti-V beta 8.2 antibody therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381155      PMCID: PMC2190910          DOI: 10.1084/jem.177.2.387

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Restricted heterogeneity in T-cell antigen receptor V beta gene usage in the lymph nodes and arthritic joints of mice.

Authors:  T M Haqqi; G D Anderson; S Banerjee; C S David
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

2.  The Ig VH repertoire of fetal liver-derived pre-B cells is influenced by the expression of a gene linked to X-linked immune deficiency.

Authors:  G E Osman; P H Brodeur; N Rosenberg; H H Wortis
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

3.  Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides.

Authors:  M D Howell; S T Winters; T Olee; H C Powell; D J Carlo; S W Brostoff
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

4.  Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Authors:  S D Sharma; B Nag; X M Su; D Green; E Spack; B R Clark; S Sriram
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

5.  Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.

Authors:  A A Vandenbark; G Hashim; H Offner
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

6.  Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors.

Authors:  S Candéias; J Katz; C Benoist; D Mathis; K Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

7.  The T cell receptor V alpha 11 gene family. Analysis of allelic sequence polymorphism and demonstration of J alpha region-dependent recognition by allele-specific antibodies.

Authors:  S C Jameson; P B Nakajima; J L Brooks; W Heath; O Kanagawa; N R Gascoigne
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

8.  Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies.

Authors:  G Chiocchia; M C Boissier; C Fournier
Journal:  Eur J Immunol       Date:  1991-12       Impact factor: 5.532

9.  Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies.

Authors:  D M Zaller; G Osman; O Kanagawa; L Hood
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

10.  T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice.

Authors:  N Nakano; H Kikutani; H Nishimoto; T Kishimoto
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  23 in total

1.  Antigen-specific expansion of TCR Vbeta3+ CD4+ T cells in the early stage of collagen-induced arthritis and its arthritogenic role in DBA/1J mice.

Authors:  Jae-Seon Lee; Mi-La Cho; Joo-Yeon Jhun; So-Youn Min; Ji-Hyeon Ju; Chong-Hyeon Yoon; Jun-Ki Min; Sung-Hwan Park; Ho-Youn Kim; Young-Gyu Cho
Journal:  J Clin Immunol       Date:  2006-04-29       Impact factor: 8.317

2.  Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.

Authors:  C Burkhart; G Freer; R Castro; L Adorini; K H Wiesmüller; R M Zinkernagel; H Hengartner
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

3.  Characterization of the mouse Tcra-V22 gene subfamily.

Authors:  A K Dattamajumdar; S W Li; D P Jacobson; W Ladiges; L E Hood; G E Osman
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.

Authors:  E C Andersson; B E Hansen; H Jacobsen; L S Madsen; C B Andersen; J Engberg; J B Rothbard; G S McDevitt; V Malmström; R Holmdahl; A Svejgaard; L Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 5.  Gene therapy for rheumatoid arthritis. Theoretical considerations.

Authors:  Y Chernajovsky; A Annenkov; C Herman; K Triantaphyllopoulos; D Gould; H Dreja; S P Moyes; J L Croxford; R A Mageed; O L Podhajcer; D Baker
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

6.  Rejection of cardiac allografts by T cells expressing a restricted repertoire of T-cell receptor V beta genes.

Authors:  H Shirwan; L Barwari; D V Cramer
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

Review 7.  Role of superantigens in experimental arthritis.

Authors:  A Abdelnour; Y X Zhao; T Bremell; R Holmdahl; A Tarkowski
Journal:  Springer Semin Immunopathol       Date:  1996

8.  The characterization of testicular cell (TC)-specific T-cell clones induced by intratesticular Listeria monocytogenes infection: TC-specific T cells with atypical cytokine profile transfer orchitis.

Authors:  G Matsuzaki; K H Sonoda; A Mukasa; H Yamada; T Nakamura; H Ikebe; S Hamano; K Nomoto
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

9.  Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.

Authors:  P Mukherjee; S-Y Yang; B Wu; Z Song; L K Myers; P D Robbins; P H Wooley
Journal:  Ann Rheum Dis       Date:  2005-04-28       Impact factor: 19.103

10.  Preferential Use of Public TCR during Autoimmune Encephalomyelitis.

Authors:  Yunqian Zhao; Phuong Nguyen; Jing Ma; Tianhua Wu; Lindsay L Jones; Deqing Pei; Cheng Cheng; Terrence L Geiger
Journal:  J Immunol       Date:  2016-05-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.